BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23300041)

  • 1. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.
    Karlo CA; Donati OF; Burger IA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Eur Radiol; 2013 Jun; 23(6):1738-44. PubMed ID: 23300041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
    Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
    Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
    Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.
    Lanzman RS; Robson PM; Sun MR; Patel AD; Mentore K; Wagner AA; Genega EM; Rofsky NM; Alsop DC; Pedrosa I
    Radiology; 2012 Dec; 265(3):799-808. PubMed ID: 23047841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.
    Jeong CJ; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Feb; 206(2):340-7. PubMed ID: 26797361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical shift imaging in the identification of those renal tumours that contain microscopic fat and the utility of multiparametric MRI in their differentiation.
    de Silva S; Lockhart K; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; Maclean F; Thompson J
    J Med Imaging Radiat Oncol; 2020 Dec; 64(6):762-768. PubMed ID: 32743914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
    Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
    Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
    Kang HS; Park JJ
    Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are growth patterns on MRI in small (< 4 cm) solid renal masses useful for predicting benign histology?
    Lim RS; McInnes MDF; Siddaiah M; Flood TA; Lavallee LT; Schieda N
    Eur Radiol; 2018 Aug; 28(8):3115-3124. PubMed ID: 29492598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
    Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
    AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-echo gradient chemical shift MR imaging fails to differentiate minimal fat renal angiomyolipomas from other homogeneous solid renal tumors.
    Ferré R; Cornelis F; Verkarre V; Eiss D; Correas JM; Grenier N; Hélénon O
    Eur J Radiol; 2015 Mar; 84(3):360-365. PubMed ID: 25547327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
    Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
    Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.